Manhattan Scientifics, Inc. (MHTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0006
-0.0001 (-14.29%)
Dec 20, 2024, 4:00 PM EST
Manhattan Scientifics Company Description
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States.
It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications.
The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
Manhattan Scientifics, Inc.
| Country | United States |
| Founded | 1992 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Emmanuel Tsoupanarias |
Contact Details
Address: 244 Fifth Avenue New York, Delaware 10001 United States | |
| Phone | 212-541-2405 |
| Website | mhtx.com |
Stock Details
| Ticker Symbol | MHTX |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US5631221000 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Emmanuel Tsoupanarias | President, Chief Executive Officer and Director |
| Marvin Maslow | Founder and Chairman of the Board |
| Leonard C. Friedman | Secretary |
| Robert Romeo Proulx | President of Imagion |